Groupe d'Etude en Oncologie du Quebec

Titre	Breast Cancer Plasma Adjuvant Intra-operative Treatment
Protocole ID	Breast Cancer PAINT
ClinicalTrials.gov ID	NCT06222788
Type(s) de cancer	Sein
Phase	Autres
Type étude	Clinique
Médicament	Non-thermal plasma (NTP)
Institution	CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
Ville	Montréal
Investigateur(trice) principal(e)	Dr Philip Wong
Coordonnateur(trice)	Ana Lydia Tkalec 514-890-8000 poste 14186
Statut	Actif en recrutement
Critètes d'éligibilité	Age ≥18 years at the time of signing study consent. ECOG ≤2. Patient with T1-4 breast cancer for groups A and B; patient with T1/T2 breast cancer for group C (based on physical exam, not radiological measurements). Patient is scheduled to undergo a lumpectomy.
Critètes d'exclusion	Prior treatment for the tumor of interest (including chemotherapy, immunotherapy, radiotherapy). Patient planning to or undergoing intraoperative radiotherapy. Diabetes (types I and II). Hypercortisolism. Collagen vascular disease. Patient requiring systemic corticosteroids at physiologic doses exceeding 10 mg/day of prednisone or its equivalent. Patient receiving daily chemotherapy for rheumatological conditions. Pregnancy (a urine pregnancy test must be obtained for non-sterile women of childbearing potential prior to surgery).

Groupe d'étude en oncologie du Québec